Identification and characterization of a novel peptide ligand of epidermal growth factor receptor for targeted delivery of therapeutics
Open Access
- 29 August 2005
- journal article
- research article
- Published by Wiley in The FASEB Journal
- Vol. 19 (14), 1978-1985
- https://doi.org/10.1096/fj.05-4058com
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Tumor-targeted gene delivery via anti-HER2 antibody (trastuzumab, Herceptin®) conjugated polyethylenimineJournal of Controlled Release, 2004
- Radiolabelled peptides for tumour therapy: current status and future directionsEuropean Journal of Nuclear Medicine and Molecular Imaging, 2003
- Peptides as Carrier for Tumor Diagnosis and TreatmentCurrent Medicinal Chemistry - Anti-Cancer Agents, 2001
- Identification of Peptides That Target the Endothelial Cell–Specific LOX-1 ReceptorHypertension, 2001
- Identification of a peptide blocking vascular endothelial growth factor (VEGF)-mediated angiogenesisThe EMBO Journal, 2000
- The Epidermal Growth Factor Receptor and Its Inhibition in Cancer TherapyPharmacology & Therapeutics, 1999
- Membrane Dipeptidase Is the Receptor for a Lung-targeting Peptide Identified by in Vivo Phage DisplayOnline Journal of Public Health Informatics, 1999
- Epidermal growth factor-related peptides and their receptors in human malignanciesCritical Reviews in Oncology/Hematology, 1995
- Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell killJournal of Immunological Methods, 1989
- Protein kinase C phosphorylation at Thr 654 of the unoccupied EGF receptor and EGF binding regulate functional receptor loss by independent mechanismsCell, 1986